156 related articles for article (PubMed ID: 36043381)
1. Design, Synthesis and Anticancer Activity of Novel Steroidal Derivatives with D-Ring Fused or Substituted N-Heterocyclic Systems.
Li XS; Yang MX; Luo YH; Zhan HH; Chen MF; Huang YM; Liu L; Yang XM
Chem Biodivers; 2022 Oct; 19(10):e202200648. PubMed ID: 36043381
[TBL] [Abstract][Full Text] [Related]
2. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
4. Steroidal[17,16-d]pyrimidines derived from dehydroepiandrosterone: A convenient synthesis, antiproliferation activity, structure-activity relationships, and role of heterocyclic moiety.
Ke S; Shi L; Zhang Z; Yang Z
Sci Rep; 2017 Mar; 7():44439. PubMed ID: 28290501
[TBL] [Abstract][Full Text] [Related]
5. DFT/B3LYP calculations, in vitro cytotoxicity and antioxidant activities of steroidal pyrimidines and their interaction with HSA using molecular docking and multispectroscopic techniques.
Ali A; Asif M; Alam P; Jane Alam M; Asif Sherwani M; Hasan Khan R; Ahmad S; Shamsuzzaman
Bioorg Chem; 2017 Aug; 73():83-99. PubMed ID: 28623723
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 5α, 8α-endoperoxide steroidal derivatives with hybrid side chain as anticancer agents.
Li H; Wang H; Wang J; Lin Y; Ma Y; Bu M
Steroids; 2020 Jan; 153():108471. PubMed ID: 31400390
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiproliferative activity of D-ring substituted steroidal benzamidothiazoles.
Fan NJ; He QR; Duan M; Bai YB; Tang JJ
Steroids; 2016 Aug; 112():103-8. PubMed ID: 27137356
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of Two Series of Novel A-Ring Fused Steroidal Pyrazines as Potential Anticancer Agents.
Wang S; Yuan X; Qian H; Li N; Wang J
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121303
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs.
Romero-Hernández LL; Merino-Montiel P; Meza-Reyes S; Vega-Baez JL; López Ó; Padrón JM; Montiel-Smith S
Eur J Med Chem; 2018 Jan; 143():21-32. PubMed ID: 29172080
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor antagonists and anti-prostate cancer activities of some synthesized steroidal candidates.
Bahashwan SA; Al-Omar MA; Ezzeldin E; Abdalla MM; Fayed AA; Amr AG
Chem Pharm Bull (Tokyo); 2011; 59(11):1363-8. PubMed ID: 22041072
[TBL] [Abstract][Full Text] [Related]
11. Furo[2,3-d]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study.
Song B; Nie L; Bozorov K; Niu C; Kuryazov R; Akber Aisa H; Zhao J
Chem Biodivers; 2023 Mar; 20(3):e202201059. PubMed ID: 36680784
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antitumor activity evaluation of steroidal oximes.
Gomes AR; Pires AS; Abrantes AM; Gonçalves AC; Costa SC; Varela CL; Silva ET; Botelho MF; Roleira FMF
Bioorg Med Chem; 2021 Sep; 46():116360. PubMed ID: 34425478
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
[TBL] [Abstract][Full Text] [Related]
16. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
17. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
19. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
20. Explorations of novel pyridine-pyrimidine hybrid phosphonate derivatives as aurora kinase inhibitors.
Tiwari SV; Sarkate AP; Lokwani DK; Pansare DN; Gattani SG; Sheaikh SS; Jain SP; Bhandari SV
Bioorg Med Chem Lett; 2022 Jul; 67():128747. PubMed ID: 35476959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
